Directory
>
Kevin Webster
Kevin Webster
Chief Science Officer | Frontier Medicines
Boston, Massachusetts, United States
Kevin Webster
Summary
Kevin Webster is a highly accomplished Chief Scientific Officer at Frontier Medicines, where he leads innovative research in the biopharmaceutical sector, particularly focused on cancer treatment. With a robust academic foundation, including a PhD from Yale University in Molecular Biophysics and Biochemistry, he has dedicated over three decades to advancing drug discovery and development. His extensive experience spans various leadership roles across notable companies like AstraZeneca and Bristol Myers Squibb, where he has significantly contributed to oncology research. Kevin's expertise encompasses a wide range of scientific disciplines, including biochemistry, bioinformatics, and translational medicine. He is passionate about leveraging cutting-edge technologies to create breakthrough therapies that can transform patient outcomes. Beyond his technical acumen, he is recognized for his strategic vision and ability to foster collaborative partnerships in the biotech industry. Kevin's commitment to innovation and excellence has positioned him as a thought leader in the life sciences community.
Kevin Webster
Work Experience
Chief Science Officer at
Frontier Medicines
June 2019 - Present
Sr. Vice President Cancer Biology at
Effector Therapeutics, Inc.
June 2014 - June 2019
Founder and President at
Partners In Innovation
January 2013 - June 2014
Vice President Oncology at
AstraZeneca
January 2010 - May 2013
Executive Director Cancer Bioscience at
AstraZeneca
November 2005 - January 2010
Global Product Director at
AstraZeneca
August 2006 - February 2007
Director Cancer Bioscience at
AstraZeneca
December 2001 - November 2005
Associate Director Oncology Drug Discovery at
Bristol Myers Squibb
January 1991 - January 2001
Kevin Webster
Education
Yale University, Phd
January 1986 - January 1991
State University of New York- Stony Brook, Bachelor Of Science (B.S.)
January 1982 - January 1986
Frequently Asked Questions about Kevin Webster
What is Kevin Webster email address?
Kevin Webster's primary email address is ********@frontiermeds.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Kevin Webster work for?
Kevin Webster is a Chief Science Officer at Frontier Medicines, a company specializing in Commercial physical research.
Where Kevin Webster graduated from?
Kevin Webster holds a degree in Molecular Biophysics And Biochemistry from Yale University.
How can I directly contact Kevin Webster?
To contact Kevin Webster directly, you can use the email address ********@frontiermeds.com. Complete contact information is available upon registration with Muraena.
Who is Kevin Webster?
Kevin Webster is a highly accomplished Chief Scientific Officer at Frontier Medicines, where he leads innovative research in the biopharmaceutical sector, particularly focused on cancer treatment. With a robust academic foundation, including a PhD from Yale University in Molecular Biophysics and Biochemistry, he has dedicated over three decades to advancing drug discovery and development. His extensive experience spans various leadership roles across notable companies like AstraZeneca and Bristol Myers Squibb, where he has significantly contributed to oncology research. Kevin's expertise encompasses a wide range of scientific disciplines, including biochemistry, bioinformatics, and translational medicine. He is passionate about leveraging cutting-edge technologies to create breakthrough therapies that can transform patient outcomes. Beyond his technical acumen, he is recognized for his strategic vision and ability to foster collaborative partnerships in the biotech industry. Kevin's commitment to innovation and excellence has positioned him as a thought leader in the life sciences community.
Kevin`s contact details
********@frontiermeds.com
***************@astrazeneca.com
********@effector.com
Colleagues
VP, Information Technology
Vice President, Head of Chemistry
Chief Of Staff
Co-director, Molecular Therapeutics Initiative
Vice President of DMPK
Chief Innovation Officer
Co-Founder
Vice President Finance
Chief Technology Officer
Senior Vice President, Strategy and Corporate Affairs